Trial Parameters
Condition Kidney Transplant Rejection
Sponsor University of Alberta
Study Type OBSERVATIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2019-12-01
Completion 2026-12
Interventions
MMDxProsperaHLA antibody
Brief Summary
Demonstrate the relationship between DD-cfDNA levels and HLA antibodies in blood, and the Molecular Microscope® (MMDx) Diagnostic System results in indication biopsies.
Eligibility Criteria
Inclusion Criteria: * All kidney transplant recipients undergoing a kidney biopsy for clinical indications, as determined by their physician or surgeon, will be eligible to enroll in the study. Exclusion Criteria: * Patients will be excluded from the study if they decline participation or are unable to give informed consent or multiple organ recipients.